Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Melosus   
Auth. number : EU/2/10/116
Active substance : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - meloxicam
(See WHO ATCvet Index)
Indication: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopedic and soft tissue surgery.
Alleviation of pain and inflammation in chronic musculo-skeletal disorders in cats.
Marketing Authorisation Holder: CP-Pharma Handelsgesellschaft mbH
Ostlandring 13, 31303 Burgdorf, Deutschland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/02/2011 Centralised - Authorisation EMEA/V/C/2001 (2011)1194 of 21/02/2011
12/05/2011 Centralised - Variation EMEA/V/C/2001/IB/1/G
Updated with Decision(2011)8963 of 28/11/2011
08/07/2011 Centralised - Variation EMEA/V/C/2001/IB/2
Updated with Decision(2011)8963 of 28/11/2011
30/11/2011 Centralised - Variation (2011)8963 of 28/11/2011
07/02/2013 Centralised - Variation EMEA/V/C/2001/IB/3
Updated with Decision(2014)1055 of 13/02/2014
17/02/2014 Centralised - Yearly update (2014)1055 of 13/02/2014
11/01/2016 Centralised - Renewal EMEA/V/C/2001/R/6 (2016)5501196 of 07/01/2016